SavedAdd your journal

Journals / Üroonkoloji Bülteni / 2018 / Cilt: 17 - Sayı: 1

Predictive Value of Hormonal Evaluation Before Prostate Needle Biopsy on Prostate Cancer T Stage and Prognosis

Serdar ÇELİK
KUTSAL YÖRÜKOĞLU
Ozan BOZKURT
Hüseyi̇n Alperen YILDIZ
ÖMER DEMİR
EMİNE BURÇİN TUNA
Güven ASLAN
Pages
9–13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In particular, TTE values <300 ng/dL were associated with high pathologic T stage, GS, and lymph node positivity

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study we evaluated the hormone data before prostate needle biopsy (PNB) in patients who underwent retropubic radical prostatectomy (RRP) due to prostate adenocarcinoma (PCa).
📊
Key Findings & Data:Materials and Methods: Patients were evaluated in two groups according to RRP pathologic T stage: T2 (group 1) and T3 (group 2).
💡
Conclusion & Impact:In particular, TTE values <300 ng/dL were associated with high pathologic T stage, GS, and lymph node positivity
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study we evaluated the hormone data before prostate needle biopsy (PNB) in patients who underwent retropubic radical prostatectomy (RRP) due to prostate adenocarcinoma (PCa). Correlations between the patients’ RRP pathology results, recurrence-free survival (RFS), and hormone data were investigated. Materials and Methods: Patients were evaluated in two groups according to RRP pathologic T stage: T2 (group 1) and T3 (group 2). Then patients were assessed in two groups based on total testosterone (TTE) values: >300 ng/dL and 300 ng/dL group (n=51). The biochemical recurrence rates and RFS times (87.7±13.8 months and 91.3±6.4 months, respectively) were similar between the groups (p=0.571). Conclusion: We demonstrated a correlation between locally invasive PCa and low TTE measured before PNB and low TTE density. In particular, TTE values <300 ng/dL were associated with high pathologic T stage, GS, and lymph node positivity

🔖

Cite This Article

ÇELİK, S., YÖRÜKOĞLU, K., BOZKURT, O., YILDIZ, H. A., DEMİR, Ö., TUNA, E. B., ASLAN, G. (2018). Predictive Value of Hormonal Evaluation Before Prostate Needle Biopsy on Prostate Cancer T Stage and Prognosis. Üroonkoloji Bülteni, Cilt: 17 - Sayı: 1, 9–13. https://ajindex.com/articles/334402

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997;277:1445-1451
  2. Huland H, Hammerer P, Henke RP, Huland E. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies. J Urol 1996;155:1344-1347
  3. Peller PA, Young DC, Marmaduke DP, et al. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer 1995;75:530-538
  4. Bozkurt O, Çelik S, Demir Ö, et al. Clinical significance of perineural invasion in prostate needle biopsy in patients diagnosed with extraprostatic extension and seminal vesicle invasion after radical prostatectomy. Bull Urooncol 2015;14:5-7
  5. Ongun S, Celik S, Gul-Niflioglu G, et al. Are active surveillance criteria sufficient for predicting advanced stage prostate cancer patients? Actas Urol Esp 2014;38:499-505
  6. DeLancey JO, Wood DP Jr, He C, et al. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. Urology 2013;81:354-357
  7. Ross PL, Scardino PT, Kattan MW. A catalog of prostate cancer nomograms. J Urol 2001;165:1562-1568
  8. Ide H, Terado Y, Sakamaki K, et al. Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer. Prostate Int 2013;1:109-112
  9. Çelik S, Bozkurt O, Yıldız HA, et al. Association between hormonal evaluation before prostate needle biopsy and locally advanced prostate cancer. Bull Urooncol 2016;15:52-56
  10. Çelik S, Bozkurt O, Yıldız HA, et al. Significance of pretreatment testosterone levels in prostate cancer risk groups. Bull Urooncol 2016;15:98-102
  11. Huggins C, Stevens RE, Hodges CV. Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 1941;43:209
  12. Chodak GW, Vogelzang NJ, Caplan RJ, et al. Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. JAMA 1991;265:618-621
  13. Chen SS, Chen KK, Lin AT, et al. The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis. BJU Int 2002;89:710-713
  14. Iversen P, Rasmussen F, Christensen IJ. Serum testoste